The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tumor responses and preliminary survival data in a phase II trial of ofranergene obadenovec (VB-111) combined with paclitaxel in patients with recurrent platinum resistant ovarian cancer.
 
Richard T. Penson
Research Funding - VBL Therapeutics (Inst)
 
Suzanne T. Berlin
No Relationships to Disclose
 
Ashley M Hanbury
Research Funding - VBL Therapeutics (Inst)
 
Amalia N Gonzalez
Research Funding - VBL Therapeutics (Inst)
 
Siobhan A Collins
Research Funding - VBL Therapeutics (Inst)
 
Michael Birrer
Research Funding - VBL Therapeutics (Inst)
 
Susana Campos
Research Funding - VBL Therapeutics (Inst)
 
Ariana Peralta
Research Funding - VBL Therapeutics (Inst)
 
Andrea R Leubitz
Employment - VBL Therapeutics
 
Yael Chava Cohen
Employment - VBL Therapeutics